All Insights White Paper Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

    Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

    Marketing Analytics

    Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

    Pharma companies need to find allies in the health care sector to counterbalance the growing influence from mergers like CVS-Aetna.

    Download White Paper
    Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

    US antitrust officials recently approved the proposed $69 billion CVS-Aetna merger. This merger follows a similar action taken by the Justice Department to approve the Cigna-Express Scripts merger, and partnering activities by Amazon, Berkshire Hathaway, and J.P. Morgan to get into the healthcare industry. These events taken together suggest what some have characterized as “the era of retail medicine is fast approaching.” What these changes also mean is an upcoming battle looming between big pharma, large retail, big health insurance companies, and large pharmacies with their influential PBM programs. What should companies do in response to this merger and similar changes happening in the industry?

    Contact us at insights@axtria.com with any questions.

     

    Complete the brief form to download the white paper

    Trending insights

    CVS-Aetna Merger White Paper

    Blog

    Top Data Challenges During Pharma Mergers and Acquisitions

    CVS-Aetna Merger White Paper

    White Paper

    Do Pharma Mergers And Acquisitions Improve R&D Productivity And Increase Shareholder Value?

    CVS-Aetna Merger White Paper

    White Paper

    Is The CVS-Aetna Merger A Pharma Industry Transformative Event?